← All themes

Genomics & Gene Editing

Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.

199 stocks

Gene Therapy

#	Name	Holding	Trade Value	% of Portfolio	Status
2101	KCM Kensico Capital Management Greenwich, Connecticut	$0	-$64.4M	–	Closed
2102	KA Kovack Advisors Ft. Lauderdale, Florida	$0	-$212K	–	Closed
2103	LMAM Legg Mason Asset Management Tokyo, Japan	$0	-$587K	–	Closed
2104	LBG Lloyds Banking Group London, United Kingdom	$0	-$1.74M	–	Closed
2105	LPC Loeb Partners Corp New York	$0	-$4.97M	–	Closed
2106	LOCB Lombard Odier & Cie (Bahamas) Nassau, Bahamas	$0	-$61K	–	Closed
2107	LFM Lumina Fund Management New York	$0	-$7.29M	–	Closed
2108	MAS Madden Advisory Services Jacksonville, Florida	$0	-$40K	–	Closed
2109	MSU Maple Securities USA Jersey City, New Jersey	$0	-$849K	–	Closed
2110	MCM Matarin Capital Management New York	$0	-$240K	–	Closed
2111	MC Menta Capital San Francisco, California	$0	-$149K	–	Closed
2112	MWVC Morgens Waterfall Vintiadis & Co New York	$0	-$5.12M	–	Closed
2113	NAP New Amsterdam Partners New York	$0	-$4.12M	–	Closed
2114	PGIM Pacific Global Investment Management Glendale, California	$0	-$261K	–	Closed
2115	PA Para Advisors New York	$0	-$4.87M	–	Closed
2116	PM Parametrica Management Wanchai, Hong Kong	$0	-$210K	–	Closed
2117	PRA Parametric Risk Advisors Westport, Connecticut	$0	-$553K	–	Closed
2118	Pathstone Family Office Englewood, New Jersey	$0	-$51K	–	Closed
2119	Plancorp LLC Saint Louis, Missouri	$0	-$532K	–	Closed
2120	PRC Platte River Capital Denver, Colorado	$0	-$306K	–	Closed
2121	PCM Potomac Capital Management New York	$0	-$445K	–	Closed
2122	PRHC P.R. Herzig & Co Roslyn Heights, New York	$0	-$633K	–	Closed
2123	QC QCM Cayman Houston, Texas	$0	-$531K	–	Closed
2124	RCM Raging Capital Management Rocky Hill, New Jersey	$0	-$7.75M	–	Closed
2125	RC Roundview Capital Princeton, New Jersey	$0	-$3.08M	–	Closed